Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
14.90
+0.10 (0.68%)
At close: Dec 19, 2025, 4:00 PM EST
15.01
+0.11 (0.74%)
After-hours: Dec 19, 2025, 7:59 PM EST
Oscar Health Revenue
Oscar Health had revenue of $2.93B in the quarter ending September 30, 2025, with 23.58% growth. This brings the company's revenue in the last twelve months to $11.09B, up 38.01% year-over-year. In the year 2024, Oscar Health had annual revenue of $8.99B with 57.55% growth.
Revenue (ttm)
$11.09B
Revenue Growth
+38.01%
P/S Ratio
0.33
Revenue / Employee
$4,703,595
Employees
2,400
Market Cap
3.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.99B | 3.28B | 57.55% |
| Dec 31, 2023 | 5.71B | 1.77B | 45.00% |
| Dec 31, 2022 | 3.94B | 2.10B | 114.33% |
| Dec 31, 2021 | 1.84B | 1.38B | 303.58% |
| Dec 31, 2020 | 455.04M | -13.83M | -2.95% |
| Dec 31, 2019 | 468.86M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
OSCR News
- 14 days ago - Oscar Health: Banking On The ACA Enrollment Expansion (Rating Upgrade) - Seeking Alpha
- 14 days ago - Oscar Health: ACA Chaos, ICHRA Growth, And A Potential 2027 Re-Rating - Seeking Alpha
- 23 days ago - Health Insurers Stocks Reflect Obamacare Subsidy Deal Can Be Reached - Forbes
- 23 days ago - Why This Health Care Stock Has Gained 35% This Week - Investopedia
- 24 days ago - OSCR Stock Review: Strong Growth Meets Attractive Valuation - Forbes
- 25 days ago - Anticipation of This Trump Proposal Is Sending Health Insurance Stocks Higher Monday - Investopedia
- 25 days ago - Oscar Health stock: why Obamacare extension isn't a strong enough reason to own it - Invezz
- 25 days ago - Oscar Health Stock Surges 22% and Centene Jumps 10%. Here's Why. - Barrons